Choose timezone
Your profile timezone:
Description
Abstract: Nusano, Inc. based in Salt Lake City is a privately held physics company committed to bringing supply stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market, and to serving industrial and commercial markets dependent on reliable access to high quality radioisotopes for their products and services. Driven by the company’s proprietary ion source, the Nusano production platform will generate radioisotopes in volumes and varieties exceeding other production methods. Nusano’s breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries.
In this seminar the speaker will provide an introduction to the Nusano linear accelerator and beam distribution platform – its unique features, current status, timeline to production, and future prospects.
Elvin Harms is the Senior Director of R&D for Nusano and as such is part of the team assembling and bringing its Linac into first operation. After a nearly 45-year career at Fermilab, wholly in its Accelerator Division, he joined Nusano and relocated to Salt Lake City in December 2023. Elvin was involved in many accelerator endeavors at Fermilab and beyond including the Tevatron collider, Antiproton source, A0 Photoinjector, ILC design, European XFEL, LCLS-II, and L2 Manager for PIP-II Accelerator Systems. He is also a veteran instructor with the US Particle Accelerator School.